Join to View Full Profile
529 S Jackson StLouisville, KY 40202
Phone+1 502-562-4370
Fax+1 502-217-5141
Dr. Grewal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2012 - 2015
Trinity Health Ann Arbor HospitalResidency, Internal Medicine, 2005 - 2008
Christian Medical College LudhianaClass of 2002
University of Illinois at ChicagoMPH- Michigan State UniversityMS
- University of LouisvillePhD
Certifications & Licensure
KY State Medical License 2012 - 2026
IN State Medical License 2018 - 2025
ME State Medical License 2018 - 2019
MA State Medical License 2017 - 2018
MI State Medical License 2005 - 2015
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2021 Aug 09
Roles: Contact
- The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors Start of enrollment: 2021 Feb 25
Roles: Principal Investigator
Publications & Presentations
PubMed
- 1 citationsPhase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab ...Diwakar Davar, Ludimila Cavalcante, Nehal Lakhani, Justin Moser, Michael Millward
Journal for Immunotherapy of Cancer. 2024-08-03 - 5 citationsPhase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.Guru P Sonpavde, Benjamin Louis Maughan, Bradley Alexander McGregor, Xiao X Wei, Kerry L Kilbridge
Cancer Immunology, Immunotherapy. 2023-03-01 - 318 citationsEfficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial.Mary L. Disis, Matthew H. Taylor, Karen Kelly, J. Thaddeus Beck, Michael S. Gordon
JAMA Oncology. 2019-03-01
Press Mentions
Knowde Group Inc.™ Enters into a Strategic Partnership with LMC Manna Research to Drive Quality and Collaboration in the Conduct of Cannabis and Psychedelic Clinical TrialsJuly 19th, 2021
Other Languages
- Hindi, Punjabi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
